Recipharm equips Lisbon facility with serialisation capabilities

pharmafield logo - pharma news

Contract development and manufacturing organisation Recipharm has equipped its sixth facility with serialisation capabilities ahead of the US and European regulation enforcement deadlines.

The facility in Lisbon is the latest of Recipharm’s facilities to be prepared to start supplying serialised products to the US and Europe, following a EUR 40 million investment into its company-wide implementation programme in 2016.

Recipharm has already delivered over 1.3 million serialised and aggregated packs to markets including China, South Korea, Saudi Arabia and Turkey, where serialisation regulations are currently in place.

The Lisbon site adds an additional four packaging lines to the company’s current serialisation capabilities. This will be followed by a further seven lines at the facility by Q2 in 2018.

Staffan Widengren, Director of Corporate Projects at Recipharm and head of the global steering committee for Recipharm’s serialisation project said: “Recipharm recognised the complexity of implementing serialisation at a very early stage. The Lisbon facility brings us to over a third of the way through our implementation project and is an important milestone in our journey.

“We introduced our serialisation programme to ensure a consistent roll-out of our standard solution, without the implementation process having a significant impact on production activities. It’s important our solution works at a local level, as well as company-wide, and the central team that heads up the programme is tasked with making this happen.”

The next site to be equipped will be the company’s facility in Brescia, which will supply serialised product to the US.